Paperpal Prime Logo

Acta Pharmaceutica : Impact Factor & More

eISSN: 1846-9558pISSN: 1330-0075
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.9
Recommended pre-submission checks
Powered by Paperpal by Editage

Acta Pharmaceutica Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SCIENDO
Language English
Frequency Quarterly
Article Processing ChargesEUR 900
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCroatian Pharmaceutical Society
FrequencyQuarterly
Publication Start Year1951
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Acta Pharmaceutica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Pharmaceutica

Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Freeze-dried kit formulation and physicochemical assessment of a daratumumab-based radiopharmaceutical.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
β-Carboline and chloroquine hybrids as potent antiplasmodial agents: Design, synthesis and biological evaluation.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Electron paramagnetic resonance studies of free radicals: The research legacy of Janko N. Herak.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
SEM/EDS analysis as a complementary tool for continuous improvement of cefixime granules for oral suspension.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Targeting atherosclerotic inflammation: Advances in NLRP3 inflammasome inhibitors beyond LDL-C.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Freeze-dried kit formulation and physicochemical assessment of a daratumumab-based radiopharmaceutical.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
β-Carboline and chloroquine hybrids as potent antiplasmodial agents: Design, synthesis and biological evaluation.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Electron paramagnetic resonance studies of free radicals: The research legacy of Janko N. Herak.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
SEM/EDS analysis as a complementary tool for continuous improvement of cefixime granules for oral suspension.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Targeting atherosclerotic inflammation: Advances in NLRP3 inflammasome inhibitors beyond LDL-C.
  • 1 Jun 2026
  • Acta pharmaceutica (Zagreb, Croatia)

FAQs on Acta Pharmaceutica